Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Wiener Boerse
21/08/2026
|
5-day change | 1st Jan Change | ||
| 59.60 EUR | -1.57% |
|
+3.47% | -5.85% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 305.84Cr 357.03Cr 286.16Cr 261.95Cr 491.6Cr 34TCr 498.1Cr 3.38TCr 1.32TCr 17TCr 1.34TCr 1.31TCr 57TCr | P/E 2026 * |
21.4x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 304.21Cr 355.14Cr 284.65Cr 260.56Cr 489Cr 34TCr 495.46Cr 3.36TCr 1.31TCr 17TCr 1.33TCr 1.3TCr 56TCr | EV / Sales 2026 * |
3.94x | EV / Sales 2027 * | 3.34x |
| Free-Float |
31.63% | Yield 2026 * |
1.61% | Yield 2027 * | 1.95% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -1.57% | ||
| 1 week | +3.47% | ||
| Current month | +1.62% | ||
| 1 month | +5.77% | ||
| 3 months | +0.76% | ||
| 6 months | -23.74% | ||
| Current year | -5.85% |
| 1 week | 57.35 |  | 60.7 |
| 1 month | 57.35 | | 60.7 |
| Current year | 53.15 | | 86.6 |
| 1 year | 53.15 | | 86.6 |
| 3 years | 45.82 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.57% | +3.47% | - | - | 357.03Cr | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,11900Cr | |
| +1.07% | +3.80% | +50.73% | +62.78% | 65TCr | |
| +1.20% | +6.21% | +25.81% | +78.74% | 47TCr | |
| +1.02% | +5.77% | +43.63% | +48.43% | 37TCr | |
| +0.85% | +4.07% | +24.97% | +40.58% | 30TCr | |
| +1.26% | +6.81% | +2.27% | +14.41% | 26TCr | |
| +1.88% | +5.81% | +49.57% | +70.53% | 24TCr | |
| +1.59% | +2.09% | -17.33% | -52.62% | 21TCr | |
| +1.87% | +5.61% | +27.32% | +91.38% | 18TCr | |
| Average | +1.01% | +4.97% | +31.49% | +53.44% | 42.22TCr | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.26% | +72.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 90Cr 72Cr 66Cr 124.04Cr 8.62TCr 125.68Cr 853.08Cr 332.67Cr 4.33TCr 338.27Cr 330.91Cr 14TCr | 89Cr 103.99Cr 83Cr 76Cr 143.19Cr 9.95TCr 145.08Cr 984.75Cr 384.02Cr 5TCr 390.48Cr 381.98Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.44TCr 21Cr 142.1Cr 55Cr 721.24Cr 56Cr 55Cr 2.39TCr | 17Cr 20Cr 16Cr 15Cr 28Cr 1.94TCr 28Cr 192.23Cr 75Cr 975.68Cr 76Cr 75Cr 3.23TCr |
| Net Debt | -1.62Cr -1.89Cr -1.52Cr -1.39Cr -2.61Cr -181.1Cr -2.64Cr -18Cr -6.99Cr -91Cr -7.11Cr -6.95Cr -300.91Cr | -8.15Cr -9.52Cr -7.63Cr -6.98Cr -13Cr -910.41Cr -13Cr -90Cr -35Cr -457.34Cr -36Cr -35Cr -1.51TCr |
| Date | Price | Change |
|---|---|---|
| 21/26/21 | €59.60 | -1.57% |
| 20/26/20 | €60.55 | +3.33% |
| 19/26/19 | €58.60 | +1.38% |
| 18/26/18 | €57.80 | 0.00% |
| 17/26/17 | €57.80 | +0.35% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
